New information and annoucements from Women's Health Practice

October 2015

In This Issue

Menopause: Making Peace With Change

Addyi

IVF Linked to Ovarian Cancer

Research Studies Now Enrolling

From Gyno Gab

Quick Links

Women's Health Practice Website

Make an Appointment

Dr. Trupin's Gyno Gab

Stay Connected

Women's Health Practice

Suzanne Trupin, M.D.
Meghan Craig, P.A.
Rachel Elbl, WHNP-BC

Thank you for subscribing to the Women's Health Practice monthly newsletter. Please enjoy updates about our office, pertinent health topics, research enrollment opportunities, and discussions focused on women's health and well-being.

Menopause: Making Peace With Change

Dr. Trupin's updated edition is now available as an eBook for Amazon Kindle!

Visit amazon.com to purchase Section I for only $1.99.

"Menopause: Making Peace With Change is a must read for women who proactively want to partake in the discussion about menopause, normal changes versus medical conditions, the use of medications, and answers to questions they may have regarding the health decisions they will need to make."

Addyi, the First Medication for HSDD

Dr. Trupin and Meghan Craig, PA are now certified prescribers of Addyi: the first drug approved to treat female sexual desire disorder. Pharmacies are currently honoring prescriptions.

Visit www.addyi.com to learn more, then make an appointment with Women's Health Practice to find out if Addyi is the right choice for you.

IVF Linked to Increased Risk of Ovarian Cancer

New research suggests that women who have undergone in vitro fertilization (IVF) may be significantly more likely to develop ovarian cancer. The study, conducted by University College London, has prompted British health experts to suggest IVF patients receive regular ovarian cancer screenings. Read more.

If you have questions about IVF or what these findings may mean to you, call Women's Health Practice at 217-356-3736 or contact us through our website.

Research Studies Now Enrolling
Participants in our studies help advance medical research for the benefit of all women, and receive study-related medical treatment at no cost. Please read the following announcements and call us if you are interested in enrolling.

Vaginal Contraceptive Ring

If you are a female between the ages of 18 and 35 you may be eligible for a contraceptive ring investigational contraceptive medication study. Qualified participants will receive study - related medical evaluations and care at no cost. If interested, please call 217-356-3736.

Do You Have Vaginal Symptoms?

Women's Health Practice is testing new investigational medications for vaginal infections. We are currently seeking women to participate in a clinical research study. If you have any of the following vaginal symptoms, you may qualify:

Itching
Buring
Irritation
Odor
Discharge

To be eligible, you must meet certain other requirements that will be explained to you. Women selected for the study will receive free study-related medical care, including 2 or 3 clinic visits, and payment for their time and travel expenses. For more information, or to see if you qualify, contact Women's Health Practice at 217-356-3736.

Uterine Fribroids and Abnormal Bleeding: VENUS Research Study

If you are a female between the ages of 18 and 50 years old and are experiencing abnormal bleeding due to uterine fibroids, you may be able to take part in the VENUS research study, testing an investigational medicine. Qualified participants will receive study-related medical evaluations and care at no cost. If interested, please go to www.venusresearchstudy.com or call 217-356-3736.

From Dr. Trupin's Blog

The Menopausal Transition

Menopause is a significant life event that all women will experience; but the timing, symptoms, and treatment are as unique as each of us. Participating in the conversation about your own health is essential to receiving the most effective treatment. Whether you are currently managing your symptoms, or still have many fertile years left, take the opportunity to educate yourself with help from Gyno Gab and Dr. Trupin's book, Menopause: Making Peace With Change .

Talk To Your Gyno Before Stopping Hormone Therapy

Starting hormone therapy early in menopause or perimenopause can lower risks of heart disease and osteoporosis, but stopping after menopausal symptoms subside may have serious consequences. A healthy lifestyle and regular monitoring by your gyno are essential to preventing harmful side effects. Read More.

Did We Cure Involutional Melancholy?

Is involutional melancholy cured? Not exactly. Once considered a separate mood disorder associated with aging and menopause, it is no longer classified as a condition separate from other forms of depression and anxiety. Depression is treatable, and WHP can help.